EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective

Boyeon Kim iD, Jee-Hyung Lee iD

International Journal of Molecular Sciences · 24.06.2026 · 27 (13) · 5682

DOI: 10.3390/ijms27135682 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2026. Verfasst von Boyeon Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea University Anam Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains among the most therapeutically intractable malignancies, with a 5-year survival rate of approximately 10% and near-universal resistance to immune checkpoint inhibitor (ICI) therapy. This refractoriness arises from the convergence of pronounced intratumoral heterogeneity (ITH) and a profoundly immunosuppressive tumor microenvironment (TME), which together configure PDAC as a prototypical immune-excluded tumor. Beyond low tumor mutational burden, PDAC exhibits layered genetic, epigenetic, transcriptional, and metabolic heterogeneity that enables rapid adaptation and immune evasion under selective pressure, while dense desmoplastic stroma, cancer-associated fibroblasts (CAFs), and immunosuppressive immune populations collectively impose formidable physical and immunologic barriers to antitumor immunity. In this review, we synthesize multi-omics, spatial transcriptomic, and immunologic evidence to elucidate how ITH and the TME dynamically interact to reinforce immune resistance. We examine reciprocal crosstalk mechanisms—including immune-driven clonal selection, interclonal cooperation, metabolic niche specialization, and metabolic–epigenetic coupling—and discuss emerging platforms such as single-cell spatial omics, patient-derived organoid immune co-culture systems, and longitudinal circulating tumor DNA monitoring that enable high-resolution mapping of ITH–TME dynamics. Finally, we evaluate ITH–TME-guided combination therapeutic strategies targeting oncogenic drivers, stromal architecture, myeloid suppression, and metabolic checkpoints, and propose a prioritized framework for near-term and speculative clinical translation in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentCarcinoma, Pancreatic DuctalPancreatic NeoplasmsImmunotherapyHumansMultiomicsPrecision MedicineAnimals

Stichwörter der Autor:innen

cancer-associated fibroblastsimmune exclusionimmunotherapy resistanceintratumoral heterogeneitymetabolic plasticitypancreatic ductal adenocarcinomapatient-derived organoidsprecision immuno-oncologyspatial transcriptomicstumor microenvironment

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Cancer Institute, Korea University, Seoul 02841, Republic of Korea.
  • Center for Organoid Research & Development, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Center for Innovative Drug Discovery, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Advanced Medical Imaging Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea.

ORCID-Profile: Boyeon Kim, Jee-Hyung Lee

Förderung

  • Korea University Anam Hospital

Zitieren

APA

Kim, B., & Lee, J. H. (2026). Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective. International Journal of Molecular Sciences, 27(13), 5682. https://doi.org/10.3390/ijms27135682

Vancouver

Kim B, Lee JH. Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective. International Journal of Molecular Sciences. 2026;27(13):5682. doi:10.3390/ijms27135682

BibTeX
@article{Kim2026,
  author = {Kim, Boyeon and Lee, Jee-Hyung},
  title = {Intra-Tumor Heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC)—Microenvironmental Interaction and Precision Immunotherapy Strategies: A Multi-Omics-Based Integrated Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5682},
  doi = {10.3390/ijms27135682}
}
Kostenlos starten →